In March 2024, Kate Middleton, the Princess of Wales, publicly announced her cancer diagnosis and her decision to undergo prophylactic chemotherapy. After nine months of treatment, she completed chemotherapy in September and resumed her royal duties, including a visit to London’s Royal Marsden Hospital where she was confirmed to be in remission.

Despite returning to public life, Kate revealed during a July visit to Colchester Hospital that the “post-treatment phase” of her cancer journey has been very challenging. She described the period after chemotherapy as “really, really difficult,” sharing how she struggled to function normally at home despite no longer being under clinical supervision.

Kate emphasized the importance of support during this phase, explaining that guidance and counseling are crucial for patients adjusting to life after treatment. She called this transition “groundbreaking” not only for patients but also for their families, acknowledging the emotional rollercoaster and the time it takes to find a “new normal.”

The Princess of Wales is a mother of three—Prince George, Princess Charlotte, and Prince Louis—and her openness about her struggles has brought attention to the often overlooked challenges faced by cancer survivors in recovery. Her candidness helps shed light on the need for ongoing care beyond active treatment.

In addition to her health update, Kate and Prince William were recently appointed to new royal roles, allowing them to issue royal warrants for the first time. These warrants serve as a prestigious endorsement of British businesses, highlighting their commitment to supporting creativity and industry in the UK.